Patent details
EP3154523 Title: FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE
Basic Information
- Publication number:
- EP3154523
- PCT Application Number:
- IB2015054506
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP157413287
- PCT Publication Number:
- WO2015193788
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- FORMULATION FOR ORAL ADMINISTRATION CONTAINING MESALAZINE
- French Title of Invention:
- FORMULATION POUR ADMINISTRATION PAR VOIE ORALE CONTENANT DE LA MÉSALAZINE
- German Title of Invention:
- FORMULIERUNG ZUR ORALEN VERABREICHUNG MIT MESALAZIN
- SPC Number:
Dates
- Filing date:
- 15/06/2015
- Grant date:
- 21/11/2018
- EP Publication Date:
- 19/04/2017
- PCT Publication Date:
- 23/12/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/11/2018
- EP B1 Publication Date:
- 21/11/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/06/2019
- Expiration date:
- 15/06/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/11/2018
- Name:
- VALPHARMA INTERNATIONAL S.P.A.
- Address:
- Via G. Morgagni, 2, 47864 Pennabilli, Italy (IT)
Inventor
1
- Name:
- AVANESSIAN, Serozh
- Address:
- Italy (IT)
2
- Name:
- VALDUCCI, Roberto
- Address:
- Italy (IT)
Priority
- Priority Number:
- FI20140148
- Priority Date:
- 16/06/2014
- Priority Country:
- Italy (IT)
Classification
- IPC classification:
- A61K 9/16; A61K 9/50; A61K 31/606;
Publication
European Patent Bulletin
- Issue number:
- 201847
- Publication date:
- 21/11/2018
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|